![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Slc66a1 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Slc66a1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PQLC2 mRNA | CTD | PMID:36331819 | Slc66a1 | Rat | (2,4,5-trichlorophenoxy)acetic acid | increases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:18579281 | Slc66a1 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of PQLC2 mRNA | CTD | PMID:22206623 | Slc66a1 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Slc66a1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC66A1 mRNA | CTD | PMID:17942748 | Slc66a1 | Rat | 17beta-estradiol | affects expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Estradiol affects the expression of SLC66A1 mRNA | CTD | PMID:39298647 | Slc66a1 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of SLC66A1 mRNA | CTD | PMID:29581250 | Slc66a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Slc66a1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC66A1 mRNA | CTD | PMID:17942748 | Slc66a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC66A1 mRNA | CTD | PMID:22298810 | Slc66a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC66A1 mRNA | CTD | PMID:21570461 | Slc66a1 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of SLC66A1 mRNA | CTD | PMID:21346803 | Slc66a1 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC66A1 mRNA | CTD | PMID:20188158 | Slc66a1 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of SLC66A1 mRNA | CTD | PMID:39298647 | Slc66a1 | Rat | aflatoxin B1 | decreases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of SLC66A1 mRNA | CTD | PMID:19770486 | Slc66a1 | Rat | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of SLC66A1 mRNA | CTD | PMID:33354967 | Slc66a1 | Rat | aristolochic acid A | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of PQLC2 mRNA | CTD | PMID:33212167 | Slc66a1 | Rat | arsane | affects methylation | ISO | SLC66A1 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SLC66A1 gene | CTD | PMID:25304211 | Slc66a1 | Rat | arsane | multiple interactions | ISO | SLC66A1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC66A1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC66A1 mRNA | CTD | PMID:39836092 | Slc66a1 | Rat | arsenic atom | affects methylation | ISO | SLC66A1 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SLC66A1 gene | CTD | PMID:25304211 | Slc66a1 | Rat | arsenic atom | multiple interactions | ISO | SLC66A1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC66A1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC66A1 mRNA | CTD | PMID:39836092 | Slc66a1 | Rat | azathioprine | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Azathioprine results in increased expression of SLC66A1 mRNA | CTD | PMID:22623647 | Slc66a1 | Rat | benzo[a]pyrene | increases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SLC66A1 mRNA | CTD | PMID:21715664 and PMID:22228805 | Slc66a1 | Rat | Benzo[k]fluoranthene | decreases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | benzo(k)fluoranthene results in decreased expression of SLC66A1 mRNA | CTD | PMID:26377693 | Slc66a1 | Rat | beta-lapachone | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of PQLC2 mRNA | CTD | PMID:38218311 | Slc66a1 | Rat | bisphenol A | affects expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | bisphenol A affects the expression of SLC66A1 mRNA | CTD | PMID:30903817 | Slc66a1 | Rat | bisphenol A | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of PQLC2 mRNA | CTD | PMID:36232920 | Slc66a1 | Rat | bisphenol A | increases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SLC66A1 mRNA | CTD | PMID:34585602 | Slc66a1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC66A1 mRNA | CTD | PMID:25181051 | Slc66a1 | Rat | bisphenol F | decreases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of SLC66A1 mRNA | CTD | PMID:38685157 | Slc66a1 | Rat | cadmium atom | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Cadmium results in increased expression of SLC66A1 mRNA | CTD | PMID:24376830 | Slc66a1 | Rat | calcitriol | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SLC66A1 mRNA | CTD | PMID:21592394 | Slc66a1 | Rat | calcitriol | multiple interactions | ISO | SLC66A1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SLC66A1 mRNA | CTD | PMID:21592394 | Slc66a1 | Rat | carbon nanotube | increases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | Slc66a1 | Rat | CGP 52608 | multiple interactions | ISO | SLC66A1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SLC66A1 gene] | CTD | PMID:28238834 | Slc66a1 | Rat | choline | multiple interactions | ISO | Slc66a1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC66A1 mRNA | CTD | PMID:20938992 | Slc66a1 | Rat | cisplatin | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of SLC66A1 mRNA | CTD | PMID:27594783 | Slc66a1 | Rat | clofibrate | decreases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of SLC66A1 mRNA | CTD | PMID:23811191 | Slc66a1 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of SLC66A1 mRNA | CTD | PMID:26033743 | Slc66a1 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of SLC66A1 mRNA | CTD | PMID:26033743 | Slc66a1 | Rat | copper(II) sulfate | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of SLC66A1 mRNA | CTD | PMID:19549813 | Slc66a1 | Rat | copper(II) sulfate | increases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Copper Sulfate results in increased expression of SLC66A1 mRNA | CTD | PMID:18579281 | Slc66a1 | Rat | cyclosporin A | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SLC66A1 mRNA | CTD | PMID:20106945 more ... | Slc66a1 | Rat | doxorubicin | decreases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SLC66A1 mRNA | CTD | PMID:29803840 | Slc66a1 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of SLC66A1 mRNA | CTD | PMID:29391264 | Slc66a1 | Rat | ethanol | affects expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Ethanol affects the expression of SLC66A1 mRNA | CTD | PMID:30319688 | Slc66a1 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of SLC66A1 mRNA | CTD | PMID:24136188 | Slc66a1 | Rat | folic acid | multiple interactions | ISO | Slc66a1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC66A1 mRNA | CTD | PMID:20938992 | Slc66a1 | Rat | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of SLC66A1 mRNA | CTD | PMID:21396975 | Slc66a1 | Rat | isoflurane | decreases methylation | ISO | Slc66a1 (Mus musculus) | 6480464 | Isoflurane results in decreased methylation of SLC66A1 mRNA | CTD | PMID:35249202 | Slc66a1 | Rat | L-methionine | multiple interactions | ISO | Slc66a1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC66A1 mRNA | CTD | PMID:20938992 | Slc66a1 | Rat | manganese atom | multiple interactions | ISO | SLC66A1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC66A1 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC66A1 mRNA | CTD | PMID:39836092 | Slc66a1 | Rat | manganese(0) | multiple interactions | ISO | SLC66A1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC66A1 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC66A1 mRNA | CTD | PMID:39836092 | Slc66a1 | Rat | manganese(II) chloride | multiple interactions | ISO | SLC66A1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC66A1 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC66A1 mRNA | CTD | PMID:39836092 | Slc66a1 | Rat | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of SLC66A1 mRNA | CTD | PMID:19564919 | Slc66a1 | Rat | methamphetamine | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of SLC66A1 mRNA | CTD | PMID:19564919 | Slc66a1 | Rat | methyl methanesulfonate | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SLC66A1 mRNA | CTD | PMID:23649840 | Slc66a1 | Rat | paracetamol | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of SLC66A1 mRNA | CTD | PMID:21420995 more ... | Slc66a1 | Rat | paracetamol | affects expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SLC66A1 mRNA | CTD | PMID:17562736 | Slc66a1 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Slc66a1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PQLC2 mRNA | CTD | PMID:36331819 | Slc66a1 | Rat | phenobarbital | multiple interactions | ISO | Slc66a1 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SLC66A1 mRNA] | CTD | PMID:19482888 | Slc66a1 | Rat | phenobarbital | decreases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of SLC66A1 mRNA | CTD | PMID:19482888 | Slc66a1 | Rat | SCH 23390 | decreases expression | EXP | | 6480464 | SCH 23390 results in decreased expression of SLC66A1 mRNA | CTD | PMID:19564919 | Slc66a1 | Rat | SCH 23390 | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of SLC66A1 mRNA | CTD | PMID:19564919 | Slc66a1 | Rat | sodium arsenite | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SLC66A1 mRNA | CTD | PMID:38568856 | Slc66a1 | Rat | sodium arsenite | multiple interactions | ISO | SLC66A1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC66A1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC66A1 mRNA | CTD | PMID:39836092 | Slc66a1 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of SLC66A1 mRNA | CTD | PMID:19281266 | Slc66a1 | Rat | testosterone | multiple interactions | ISO | SLC66A1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SLC66A1 mRNA | CTD | PMID:21592394 | Slc66a1 | Rat | testosterone | increases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Testosterone results in increased expression of SLC66A1 mRNA | CTD | PMID:21592394 | Slc66a1 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SLC66A1 mRNA | CTD | PMID:34492290 | Slc66a1 | Rat | titanium dioxide | decreases methylation | ISO | Slc66a1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of PQLC2 gene | CTD | PMID:35295148 | Slc66a1 | Rat | trimellitic anhydride | increases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of SLC66A1 mRNA | CTD | PMID:19042947 | Slc66a1 | Rat | triphenyl phosphate | affects expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of PQLC2 mRNA | CTD | PMID:37042841 | Slc66a1 | Rat | triptonide | increases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | triptonide results in increased expression of SLC66A1 mRNA | CTD | PMID:33045310 | Slc66a1 | Rat | troglitazone | decreases expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Troglitazone results in decreased expression of SLC66A1 mRNA | CTD | PMID:28973697 | Slc66a1 | Rat | valproic acid | decreases expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SLC66A1 mRNA | CTD | PMID:29154799 | Slc66a1 | Rat | valproic acid | affects expression | ISO | SLC66A1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SLC66A1 mRNA | CTD | PMID:25979313 | Slc66a1 | Rat | valproic acid | affects expression | ISO | Slc66a1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of SLC66A1 mRNA | CTD | PMID:17963808 | |